Q3 2026 13F filing
Updated 2 days ago58 disclosed positions worth $515.5M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TESLA INC | $79.8M | 225.0K | 15.49% | — |
| 2 | S SHOPIFY INC | $45.2M | 305.0K | 8.77% | — |
| 3 | A ADVANCED MICRO DEVICES INC | $37.9M | 62.0K | 7.36% | — |
| 4 | S SPACE EXPLORATION TECHN CORP | $37.7M | 250.0K | 7.32% | — |
| 5 | P PALANTIR TECHNOLOGIES INC | $37.4M | 200.0K | 7.26% | — |
| 6 | A AMAZON COM INC | $34.9M | 140.0K | 6.77% | — |
| 7 | C CEREBRAS SYSTEMS INC | $19.7M | 111.0K | 3.83% | — |
| 8 | N NVIDIA CORPORATION | $18.5M | 81.0K | 3.59% | — |
| 9 | S SPOTIFY TECHNOLOGY S A | $16.1M | 33.0K | 3.12% | — |
| 10 | I IONIS PHARMACEUTICALS INC | $15.6M | 349.0K | 3.02% | — |
| 11 | I IREN LIMITED | $15.1M | 370.1K | 2.94% | — |
| 12 | A ARROWHEAD PHARMACEUTICALS IN | $14.1M | 215.8K | 2.74% | — |
| 13 | L LEMONADE INC | $12.2M | 270.3K | 2.37% | — |
| 14 | O OPENDOOR TECHNOLOGIES INC | $12.2M | 5.14M | 2.36% | — |
| 15 | B BIOGEN INC | $10.9M | 48.4K | 2.12% | — |
| 16 | N NEBIUS GROUP N.V. | $9.4M | 40.0K | 1.83% | — |
| 17 | P PROQR THRAPEUTICS N V | $9.1M | 5.47M | 1.76% | — |
| 18 | A ARCUTIS BIOTHERAPEUTICS INC | $8.8M | 333.2K | 1.71% | — |
| 19 | A AXSOME THERAPEUTICS INC. | $7.9M | 42.9K | 1.54% | — |
| 20 | B BRIDGEBIO PHARMA INC | $5.9M | 89.2K | 1.14% | — |
| 21 | Q UNIQURE NV | $5.2M | 216.2K | 1.01% | — |
| 22 | A ALNYLAM PHARMACEUTICALS INC | $5.1M | 20.6K | 0.99% | — |
| 23 | D DENALI THERAPEUTICS INC | $4.8M | 229.9K | 0.92% | — |
| 24 | B BIOMARIN PHARMACEUTICAL INC | $4.5M | 75.0K | 0.87% | — |
| 25 | U UROGEN PHARMA LTD | $4.4M | 107.9K | 0.85% | — |
| 26 | N NEUROCRINE BIOSCIENCES INC | $3.7M | 26.2K | 0.72% | — |
| 27 | R ULTRAGENYX PHARMACEUTICAL IN | $3.5M | 233.0K | 0.68% | — |
| 28 | K KRYSTAL BIOTECH INC | $3.3M | 10.0K | 0.64% | — |
| 29 | B BIONTECH SE | $3.2M | 32.1K | 0.61% | — |
| 30 | S SAREPTA THERAPEUTICS INC | $3M | 166.6K | 0.59% | — |
| 31 | A AMBEV SA | $2.9M | 989.7K | 0.56% | — |
| 32 | C CRISPR THERAPEUTICS AG | $2.7M | 49.0K | 0.53% | — |
| 33 | M MEIRAGTX HLDGS PLC | $2.3M | 208.5K | 0.44% | — |
| 34 | B BEAM THERAPEUTICS INC | $2.2M | 91.3K | 0.43% | — |
| 35 | Z ZOETIS INC | $1.7M | 23.6K | 0.32% | — |
| 36 | B B2GOLD CORP | $1.4M | 265.5K | 0.27% | — |
| 37 | F 4D MOLECULAR THERAPEUTICS IN | $1.3M | 90.1K | 0.25% | — |
| 38 | T TAYSHA GENE THERAPIES INC | $1.1M | 232.9K | 0.22% | — |
| 39 | ? N/A CARTESIAN THERAPEUTICS INC | $1.1M | 155.0K | 0.22% | — |
| 40 | F FATE THERAPEUTICS INC | $982K | 414.3K | 0.19% | — |
| 41 | A AUTOLUS THERAPEUTICS LTD | $911K | 469.5K | 0.18% | — |
| 42 | R TRANSOCEAN LTD | $816K | 155.7K | 0.16% | — |
| 43 | M MOLINA HEALTHCARE INC | $769K | 4.1K | 0.15% | — |
| 44 | L LULULEMON ATHLETICA INC | $676K | 7.0K | 0.13% | — |
| 45 | R ROCKET PHARMACEUTICALS INC | $642K | 244.1K | 0.12% | — |
| 46 | L NOV INC | $638K | 34.0K | 0.12% | — |
| 47 | ? N/A LEXEO THERAPEUTICS INC | $524K | 155.0K | 0.10% | — |
| 48 | S SANDRIDGE ENERGY INC | $523K | 38.8K | 0.10% | — |
| 49 | N NU HLDGS LTD | $483K | 38.2K | 0.09% | — |
| 50 | S SEABRIDGE GOLD INC | $402K | 14.2K | 0.08% | — |